Bubble Therapy: a New Paradigm for Targeted Drug Delivery by Ultrasound
气泡疗法:超声靶向给药的新范例
基本信息
- 批准号:EP/F011547/1
- 负责人:
- 金额:$ 140.57万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2007
- 资助国家:英国
- 起止时间:2007 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
High amplitude ultrasound waves propagating through tissue have been recently reported to induce a range of potentially beneficial phenomena, such as rapid tissue heating, increased permeability of cells to large drug molecules (sonoporation) or enhanced activity of drugs. These bioeffects are heavily correlated with the ultrasound-induced nucleation and subsequent excitation of micron-sized bubbles, yielding two types of acoustic cavitation activity: (1) inertial cavitation, which dramatically increases the energy transfer to tissue and can cause rapid heating and mechanical damage, and (2) stable cavitation, whereby bubbles act as micropumps that dramatically enhance the local mixing and transport length scales of drug molecules. In cancer treatment, local heating combined with chemotherpay will render cancer cells more sensitive to treatment, whilst local micropumping of the drug can help overcome delivery problems arising from the highly complex tumour structure. In the context of breaking down blood clots for stroke therapy, cavitation-enhanced mixing will promote delivery of the drug to a site of low blood flow and greatly increase the diffusion of the thombolyic drug across the clot surface.However, the nucleation of cavitating microbubbles and subsequent interaction with cells in biologically relevant media remain poorly understood. The objectives of the proposed research therefore are (i) to investigate the potential of cell- and site-specific cavitation nucleation using commercially available targeted nanoparticles currently being developed for molecular imaging; (ii) to understand and optimize the mechanism by which ultrasound and cavitation can enhance local drug delivery and drug activity across inaccessible interfaces such as tumours or blood clots; (iii) to develop clinically relevant means of monitoring cavitation activity and exploit them for real-time monitoring of drug delivery and (iv) to test the optimized drug delivery and treatment monitoring protocols in a clinically relevant organ model.It is hoped that the proposed resarch will pave the road for widespread clinical uptake of cavitaiton-enhanced targeted drug delivery by ultrasound. Particular advantages of this technique will include the ability to locally enhance drug activity, thus reducing the necessary drug dosages and their side effects, and to monitor therapy in real time. The outcomes of the proposed research are expected to be directly transferable to many other novel therapeutic ultrasound applications, such as non-invasive tissue ablation by High-Intensity Focussed Ultrasound (HIFU), acoustic haemostasis and ultrasound-induced opening of the blood-brain barrier for transcranial drug delivery.
最近有报道称,在组织中传播的高幅度超声波可以引起一系列潜在的有益现象,例如快速的组织加热、细胞对大分子药物的渗透性增加(声波治疗)或增强药物的活性。这些生物效应与超声诱导微米级气泡的成核和随后的激发密切相关,从而产生两种类型的声空化活动:(1)惯性空化,极大地增加向组织的能量传递,并可导致快速加热和机械损伤;(2)稳定空化,气泡充当微泵,极大地增强药物分子的局部混合和传输长度。在癌症治疗中,局部加热与化疗相结合将使癌细胞对治疗更敏感,而局部微泵药物可帮助克服高度复杂的肿瘤结构引起的输送问题。在中风治疗中,空化增强的混合将促进药物向低血流部位的输送,并极大地增加血栓表面的药物扩散。然而,空化微泡的成核以及随后与生物相关介质中的细胞的相互作用仍然知之甚少。因此,拟议研究的目标是:(I)使用目前正在开发的用于分子成像的商用靶向纳米颗粒,研究特定细胞和部位的空化成核的可能性;(Ii)了解和优化超声和空化可以增强局部药物输送和跨越肿瘤或血栓等难以接触的界面的药物活性的机制;(Iii)开发临床上相关的监测空化活动的手段,并将其用于药物输送的实时监测;(Iv)在临床相关的器官模型中测试优化的药物输送和治疗监测方案。希望拟议的研究将为空泡增强的超声靶向输送在临床上的广泛应用铺平道路。这项技术的特殊优势将包括能够在局部增强药物活性,从而减少必要的药物剂量及其副作用,并实时监测治疗情况。这项研究的成果有望直接应用于其他许多新的治疗性超声应用,如高强度聚焦超声(HIFU)的非侵入性组织消融、声学止血和超声诱导的血脑屏障开放以用于经颅给药。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting of liposomes via PSGL1 for enhanced tumor accumulation.
通过 PSGL1 靶向脂质体以增强肿瘤积累。
- DOI:10.1007/s11095-012-0875-5
- 发表时间:2013-02
- 期刊:
- 影响因子:3.7
- 作者:Carlisle, Robert;Seymour, Leonard W.;Coussios, Constantin C.
- 通讯作者:Coussios, Constantin C.
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
- DOI:10.1093/jnci/djt305
- 发表时间:2013-11-20
- 期刊:
- 影响因子:0
- 作者:Carlisle R;Choi J;Bazan-Peregrino M;Laga R;Subr V;Kostka L;Ulbrich K;Coussios CC;Seymour LW
- 通讯作者:Seymour LW
Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound
- DOI:10.1016/j.jconrel.2013.03.017
- 发表时间:2013-07-10
- 期刊:
- 影响因子:10.8
- 作者:Bazan-Peregrino, Miriam;Rifai, Bassel;Coussios, Constantin C.
- 通讯作者:Coussios, Constantin C.
Improving Delivery of Oncolytic Viruses to Solid Tumours
改善溶瘤病毒向实体瘤的递送
- DOI:
- 发表时间:2014
- 期刊:
- 影响因子:4.2
- 作者:Carlisle R.
- 通讯作者:Carlisle R.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Constantin Coussios其他文献
Prolonged normothermic perfusion of the kidney prior to transplantation: a historically controlled, phase 1 cohort study
移植前肾脏的长时间常温灌注:一项历史对照、1 期队列研究
- DOI:
10.1038/s41467-025-59829-5 - 发表时间:
2025-05-17 - 期刊:
- 影响因子:15.700
- 作者:
Richard Dumbill;Simon Knight;James Hunter;John Fallon;Daniel Voyce;Jacob Barrett;Matt Ellen;Elizabeth Conroy;Ian SD Roberts;Tim James;Gabrielle Allen;Jennifer Brook;Annemarie Weissenbacher;Rutger Ploeg;Constantin Coussios;Peter Friend - 通讯作者:
Peter Friend
Nucleation, mapping and control of cavitation for drug delivery
用于药物输送的空化成核、映射和控制
- DOI:
10.1038/s42254-019-0074-y - 发表时间:
2019-06-17 - 期刊:
- 影响因子:39.500
- 作者:
Eleanor Stride;Constantin Coussios - 通讯作者:
Constantin Coussios
Results of first-in-man proof of concept study of ultrasound-triggered drug delivery in liver tumours
- DOI:
10.1016/j.crad.2019.09.002 - 发表时间:
2019-10-01 - 期刊:
- 影响因子:
- 作者:
Paul C. Lyon;Michael Gray;Christophoros Mannaris;Lisa Folkes;Michael Stratford;Leticia Campo;Daniel Chung;Shaun Scott;Mark Anderson;Robert Goldin;Robert Carlisle;Feng Wu;Mark Middleton;Fergus Gleeson;Constantin Coussios - 通讯作者:
Constantin Coussios
Preclinical safety and feasibility of <em>in situ</em> Isolated Normothermic Liver Chemoperfusion (INLiC)
- DOI:
10.1016/j.ejso.2021.11.028 - 发表时间:
2022-01-01 - 期刊:
- 影响因子:
- 作者:
Tamsyn Clark;Georg Ebeling;Luca Baù;Daniel Voyce;Ann Ogbemudia;Constantin Coussios;Peter Friend - 通讯作者:
Peter Friend
Impaired Osub2/sub unloading from stored blood results in diffusion-limited Osub2/sub release at tissues: evidence from human kidneys
储存血液中氧卸载受损导致组织处氧释放受扩散限制:来自人体肾脏的证据
- DOI:
10.1182/blood.2023022385 - 发表时间:
2024-02-22 - 期刊:
- 影响因子:23.100
- 作者:
Richard Dumbill;Julija Rabcuka;John Fallon;Simon Knight;James Hunter;Daniel Voyce;Jacob Barrett;Matt Ellen;Annemarie Weissenbacher;Tetuko Kurniawan;Slawomir Blonski;Piotr Michal Korczyk;Rutger Ploeg;Constantin Coussios;Peter Friend;Pawel Swietach - 通讯作者:
Pawel Swietach
Constantin Coussios的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Constantin Coussios', 18)}}的其他基金
OxCD3: Oxford Centre for Drug Delivery Devices
OxCD3:牛津药物输送设备中心
- 批准号:
EP/L024012/1 - 财政年份:2014
- 资助金额:
$ 140.57万 - 项目类别:
Research Grant
ULTRASPINE: Ultrasound-Enabled Minimally Invasive Disc Replacement
ULTRASPINE:超声微创椎间盘置换术
- 批准号:
EP/K021729/1 - 财政年份:2013
- 资助金额:
$ 140.57万 - 项目类别:
Research Grant
Transcostal High Intensity Focused Ultrasound for the Treatment of Cancer
经肋高强度聚焦超声治疗癌症
- 批准号:
EP/F02617X/1 - 财政年份:2008
- 资助金额:
$ 140.57万 - 项目类别:
Research Grant
Copy of Development of methods for characterising and testing clinical High Intensity Focused Ultrasound (HIFU) systems
临床高强度聚焦超声 (HIFU) 系统表征和测试方法开发的副本
- 批准号:
EP/F01564X/1 - 财政年份:2008
- 资助金额:
$ 140.57万 - 项目类别:
Research Grant
Use of Controlled Acoustic Cavitation to Enhance and Monitor Treatment by High-Intensity Focussed Ultrasound (HIFU)
使用受控声空化来增强和监测高强度聚焦超声 (HIFU) 治疗
- 批准号:
EP/D06127X/1 - 财政年份:2006
- 资助金额:
$ 140.57万 - 项目类别:
Research Grant
相似海外基金
A new vascular regenerative therapy for myocardial ischemia using intergin-specific circulating monocytes
使用intergin特异性循环单核细胞治疗心肌缺血的新血管再生疗法
- 批准号:
24K19425 - 财政年份:2024
- 资助金额:
$ 140.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The role of LILRB3-mediated immunomodulation on myeloid cells and exploration of new combination therapy for chronic inflammation and cancer
LILRB3介导的免疫调节对骨髓细胞的作用及慢性炎症和癌症联合治疗的探索
- 批准号:
24K18478 - 财政年份:2024
- 资助金额:
$ 140.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a new lung cancer therapy targeting a MAML3-Hh/NOTCH signaling pathway
开发针对 MAML3-Hh/NOTCH 信号通路的新型肺癌疗法
- 批准号:
23K08298 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New nanotechnology for non-invasive deep lung-activatable antimicrobial photodynamic therapy of hospital-associated pneumonia
新型纳米技术用于非侵入性深部肺激活抗菌光动力治疗医院相关性肺炎
- 批准号:
478523 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
Operating Grants
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
New phase of brain tumor therapy: development of gene and cell therapy with SHED
脑肿瘤治疗的新阶段:SHED基因和细胞疗法的发展
- 批准号:
23H03019 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New Therapy for the Treatment of Primary Biliary Cholangitis.
治疗原发性胆汁性胆管炎的新疗法。
- 批准号:
10697484 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis
口服可溶纸条(ODS)作为潜伏性结核病治疗的新儿科和成人给药方式
- 批准号:
10760389 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别:
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
- 批准号:
10976161 - 财政年份:2023
- 资助金额:
$ 140.57万 - 项目类别: